| # | % | |||||
|---|---|---|---|---|---|---|
| 201 | AMGEN INC | 175 | 26,000 | 0.01% | ||
| 202 | LILLY ELI & CO | 300 | 22,000 | 0.01% | ||
| 203 | ANTARES PHARMA INC | 20,000 | 17,000 | 0.00% | ||
| 204 | INDEPENDENCE CONTRACT DRIL I COM | 3,000 | 14,000 | 0.00% | ||
| 205 | NEURODERM LTD | 1,000 | 14,000 | 0.00% | ||
| 206 | VALEANT PHARMACEUTICALS INTL | 350 | 9,000 | 0.00% | ||
| 207 | AKARI THERAPEUTICS PLC | 345 | 4,000 | 0.00% | ||
| 208 | NIKE INC | 0 | 0 | 0.00% | ||
| 209 | LYONDELLBASELL INDUSTRIES N | 0 | 0 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001085146-16-003753, filed 2016.05.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
